logo/base Created with Sketch.

Agile
4

Identifizierung von Zirrhose bei MASLD-Patienten

Agile 4 ist ein auf FibroScan® beruhender Score

wave

Agile 4: erprobt und bewährt

quote

A novel noninvasive score including LSM by VCTE™ and routine clinical parameters improves the identification of cirrhosis among patients with MASLD and may reduce the necessity of liver biopsy in this patient population.

AASLD 2020 | Quote from AASLD 2020 poster conclusion

quote

Agile 4 and Agile 3+ well predict the occurrence of liverrelated events in patients with MASLD. Particularly, rule-in cut-offs of both scores better identify at-risk patients than LSM alone. These results demonstrate the interest of those scores in the identification of patients requiring hepatocellular carcinoma and esophageal varices screening.

J. Boursier et all. | ILC 2021

chevron chevron